Publication | Open Access
Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab
105
Citations
28
References
2013
Year
Early treatment of O104:H4 STEC-HUS by eculizumab was associated with a rapid and efficient recovery. Controlled prospective evaluation of eculizumab in STEC-HUS is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1